Á lódáil...
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
BACKGROUND: With the expanded availability of next generation sequencing (NGS)-based clinical genetic tests, clinicians seeking to test patients with Mendelian diseases must weigh the superior coverage of targeted gene panels with the greater number of genes included in whole exome sequencing (WES)...
Na minha lista:
| Foilsithe in: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Public Library of Science
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5289469/ https://ncbi.nlm.nih.gov/pubmed/28152038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0170843 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|